Dr. Jue Liu is a research professor and doctoral supervisor at the School of Public Health, Institute for Global Health and Development, Peking University, and senior visiting scientist at the Harvard T.H. Chan School of Public Health. She is the deputy chair of Department of Epidemiology and Biostatistics, School of Public Health, Peking University. She is the deputy director of Peking University Health Science Center-Weifang Joint Research Center for Maternal and Child Health. Her research interests are mainly in: (1) Epidemiology of infectious diseases; (2) Maternal and child health; (3) Big data research and application in health. She has acted as Principal Investigator of more than 20 national projects funded by the National Natural Science Foundation, the Ministry of Science and Technology of China, the National Health Commission of China, etc.. She has published more than 100 peer-reviewed scientific papers as first or corresponding author, including Lancet, BMJ, etc..

She is the member of the National Expert Panel of COVID-19 in the National Health Commission of China, Deputy Secretary General of the Professional Committee on Public Health Safety of the Society for Public Safety Science and Technology, and Executive Director and Deputy Secretary General of the Risk Management Branch of the China Association for Optimal Selection and Economic Mathematics. She has served in the Expert Advisory Committee of the Chinese Delegation to the World Health Assembly and the Executive Committee of the World Health Organization since 2020. She is also the Vice Chairman of the Big Data Working Committee of Rehabilitation in the Chinese Rehabilitation Medical Association, ect..

She has awarded the first prize of the Science and Technology Award of the Chinese Preventive Medicine Association, the first prize of National Maternal and Child Health Science and Technology Award, the first prize of the Public Safety of the Science and Technology Award, and the second prize of the Science and Technology Award of the Rehabilitation Medical Association of China. She has also awarded the Beijing May Fourth Youth Medal, the Beijing Outstanding Young Talent, Peking University Academic Innovation Award, Wang Xuan Young Scholar Award, and Boya Young Scholar of Peking University.

1. Epidemiology of infectious diseases

2. Maternal and child health

3. Big data research and application in health

1. Beijing Natural Science Foundation, Key Research Project of Beijing Natural Science Foundation, Research on Epidemic Characteristics of COVID-19 and Vaccine based Prevention and Control Strategies, 2023-2025, PI

2. National Natural Science Foundation of China, International Cooperation and Exchange Project, Evidence-based Research on Strategies for the Recovery Period of the COVID-19 Pandemic: Assessment and Analysis of the Impact of the Pandemic on Public Health, 2022-2024, PI

3. National Natural Science Foundation of China, Outstanding Youth Science Fund Project, Prevention, Control and Management of Major Infectious Diseases, 2022-2025, PI

4. Ministry of Science and Technology, National Science and Technology Innovation 2030-"New Generation Artificial Intelligence" Major Project on Development and Application of the Intelligent Active Monitoring and Warning System for Global Major Outbreak Infectious Diseases, Research on Multisource Data Integration of Global Major Emerging and Re-emerging Infectious Diseases, 2021-2024, PI

5. Ministry of Science and Technology, National Regular Science and Technology Assistance Project for Developing Countries, Project on the Construction of China ASEAN Public Health Technology Cooperation Center, China ASEAN Public Health Big Data Management Platform, 2021-2024, PI

6. National Bureau of Statistics, National Statistical Science Research Project, quantitative evaluation study on response effect to major public health events such as COVID-19 prevention and control, 2021-2023, PI

7. Ministry of Science and Technology, National Key Research and Development Program, 2020YFC0846300, Research on Risk Assessment, Prevention and Control Strategies of COVID-19 During Recovery Period, 2020, PI

8. Ministry of Science and Technology, National Science and Technology Key Projects on Prevention and Treatment of Major Infectious Diseases of China, Development and application of detection products for viral hepatitis, AIDS, tuberculosis and other infectious diseases based on nucleic acid detection technology, 2020-2021, PI

9. Ministry of Science and Technology, National Key Research and Development Program, Research on the Effects of Tai Chi Chuan on Cognitive Function in Patients With Type 2 Diabetes and Mild Cognitive Impairment, 2019-2021, PI

10. National Natural Science Foundation of China, Effects of pre-pregnancy BMI, pregnancy weight gain and AHSG/RBP4/FABP4 on gestational diabetes mellitus: a prospective cohort study, 2018-2020, PI

1. Liyuan Tao, Jue Liu*. The INSPIRE study: RSV infection during infancy. Lancet. 2024;403(10428):728-729.

2. Jue Liu*. Sustainable development of leprosy elimination by 2030 in China. Lancet Reg Health West Pac. 2024 Mar 8;44:101044.:1-2.

3. Wenxin Yan, Chenyuan Qin, Liyuan Tao, Xin Guo, Qiao Liu, Min Du, Lin Zhu, Zhongdan Chen, Wannian Liang, Min Liu, Jue Liu*. Association between inequalities in human resources for health and all cause and cause specific mortality in 172 countries and territories, 1990-2019: observational study. BMJ. 2023;381:e073043.

4. Yaping Wang, Jue Liu*. Improving childhood cancer care in China. Lancet. 2023;401(10373):266-267.

5. Jue Liu, Fude Yang, Min Liu*. Screening and services for autism among children in China. Lancet Psychiatry. 2022; 9(16):e53.

6. Jue Liu, Min Liu*. The optimal screening strategy for chronic hepatitis B virus infection in China. Lancet Global Health. 2022, 6 (10), e792.

7. Jue Liu, Xiaoyan Wang, Qian Wang, Yaping Qiao, Xi Jin, Zhixin Li, Min Du, Wenxin Yan, Wenzhan Jing, Min Liu*, Ailing Wang*. Hepatitis B virus infection among 90 million pregnant women in 2853 Chinese counties, 2015-2020: a national observational study, Lancet Reg Health West Pac, 2021. 16:100267.

8. Min Du#, Jue Liu*. Mpox added to national notifiable infectious diseases in China since September 2023.Lancet Reg Health West Pac. 2023;39:100932.

9. Jue Liu, Shikun Zhang, Min Liu*, Qiaomei Wang, Haiping Shen, Yiping Zhang. Maternal pre-pregnancy infection with hepatitis B virus and the risk of preterm birth: a population-based cohort study. Lancet Glob Health. 2017;5(6):e624-e632.

10. Jue Liu, Shikun Zhang, Qiaomei Wang, Haiping Shen, Man Zhang, Yiping Zhang, Donghai Yan, Min Liu*. Seroepidemiology of hepatitis B virus infection in 2 million men aged 21-49 years in rural China: a population-based, cross-sectional study. Lancet Infect Dis. 2016;16(1):80-6.

Note：*Corresponding author